BAX
Price
$30.09
Change
+$0.54 (+1.83%)
Updated
Jun 3 closing price
Capitalization
21.77B
50 days until earnings call
STE
Price
$242.96
Change
-$0.37 (-0.15%)
Updated
Jun 4, 10:42 AM (EDT)
Capitalization
22.22B
68 days until earnings call
Interact to see
Advertisement

BAX vs STE

Header iconBAX vs STE Comparison
Open Charts BAX vs STEBanner chart's image
Baxter International
Price$30.09
Change+$0.54 (+1.83%)
Volume$3.13M
Capitalization21.77B
STERIS
Price$242.96
Change-$0.37 (-0.15%)
Volume$200
Capitalization22.22B
BAX vs STE Comparison Chart
Loading...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAX vs. STE commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a Buy and STE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (BAX: $30.09 vs. STE: $243.33)
Brand notoriety: BAX and STE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BAX: 73% vs. STE: 81%
Market capitalization -- BAX: $21.77B vs. STE: $22.22B
BAX [@Medical Specialties] is valued at $21.77B. STE’s [@Medical Specialties] market capitalization is $22.22B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAX’s FA Score shows that 1 FA rating(s) are green whileSTE’s FA Score has 2 green FA rating(s).

  • BAX’s FA Score: 1 green, 4 red.
  • STE’s FA Score: 2 green, 3 red.
According to our system of comparison, STE is a better buy in the long-term than BAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAX’s TA Score shows that 4 TA indicator(s) are bullish while STE’s TA Score has 5 bullish TA indicator(s).

  • BAX’s TA Score: 4 bullish, 5 bearish.
  • STE’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, STE is a better buy in the short-term than BAX.

Price Growth

BAX (@Medical Specialties) experienced а -1.98% price change this week, while STE (@Medical Specialties) price change was -1.17% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.85%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was +0.89%.

Reported Earning Dates

BAX is expected to report earnings on Jul 24, 2025.

STE is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Medical Specialties (+0.85% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STE($22.2B) and BAX($21.8B) have the same market capitalization . BAX has higher P/E ratio than STE: BAX (85.61) vs STE (38.85). STE YTD gains are higher at: 18.680 vs. BAX (4.269). BAX has higher annual earnings (EBITDA): 1.67B vs. STE (1.39B). BAX has more cash in the bank: 3.19B vs. STE (196M). STE has less debt than BAX: STE (3.51B) vs BAX (14.4B). BAX has higher revenues than STE: BAX (14.8B) vs STE (5.41B).
BAXSTEBAX / STE
Capitalization21.8B22.2B98%
EBITDA1.67B1.39B120%
Gain YTD4.26918.68023%
P/E Ratio85.6138.85220%
Revenue14.8B5.41B274%
Total Cash3.19B196M1,630%
Total Debt14.4B3.51B410%
FUNDAMENTALS RATINGS
BAX vs STE: Fundamental Ratings
BAX
STE
OUTLOOK RATING
1..100
6174
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
18
Undervalued
PROFIT vs RISK RATING
1..100
10034
SMR RATING
1..100
9178
PRICE GROWTH RATING
1..100
6227
P/E GROWTH RATING
1..100
1359
SEASONALITY SCORE
1..100
5024

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BAX's Valuation (8) in the Medical Specialties industry is in the same range as STE (18). This means that BAX’s stock grew similarly to STE’s over the last 12 months.

STE's Profit vs Risk Rating (34) in the Medical Specialties industry is significantly better than the same rating for BAX (100). This means that STE’s stock grew significantly faster than BAX’s over the last 12 months.

STE's SMR Rating (78) in the Medical Specialties industry is in the same range as BAX (91). This means that STE’s stock grew similarly to BAX’s over the last 12 months.

STE's Price Growth Rating (27) in the Medical Specialties industry is somewhat better than the same rating for BAX (62). This means that STE’s stock grew somewhat faster than BAX’s over the last 12 months.

BAX's P/E Growth Rating (13) in the Medical Specialties industry is somewhat better than the same rating for STE (59). This means that BAX’s stock grew somewhat faster than STE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAXSTE
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
63%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
48%
Bullish Trend 1 day ago
68%
Momentum
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
62%
MACD
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 1 day ago
53%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
54%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
56%
Advances
ODDS (%)
Bullish Trend 20 days ago
50%
Bullish Trend 17 days ago
56%
Declines
ODDS (%)
Bearish Trend 3 days ago
59%
Bearish Trend 13 days ago
50%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
65%
Aroon
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRTX7.690.13
+1.72%
TPG RE Finance Trust
CYBR394.070.24
+0.06%
CyberArk Software Ltd
BATRA43.50-0.18
-0.41%
Atlanta Braves Holdings
ECBK15.63-0.31
-1.94%
ECB Bancorp
ZCMD1.12-0.07
-5.88%
Zhongchao

BAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAX has been loosely correlated with RVTY. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BAX jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
+1.83%
RVTY - BAX
52%
Loosely correlated
+1.91%
SYK - BAX
51%
Loosely correlated
+0.04%
MTD - BAX
50%
Loosely correlated
+2.22%
STE - BAX
49%
Loosely correlated
+0.52%
A - BAX
48%
Loosely correlated
+1.54%
More

STE and

Correlation & Price change

A.I.dvisor indicates that over the last year, STE has been loosely correlated with SYK. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if STE jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STE
1D Price
Change %
STE100%
+0.52%
SYK - STE
53%
Loosely correlated
+0.04%
WAT - STE
51%
Loosely correlated
+1.66%
DHR - STE
51%
Loosely correlated
+1.50%
RVTY - STE
51%
Loosely correlated
+1.91%
LH - STE
51%
Loosely correlated
+1.07%
More